Proton MR Spectroscopy of Sjögren-Larsson's Syndrome
Toshiyuki Manoa,
Jiro Onoa,
Tatsuro Kaminagaa,
Katsumi Imaia,
Kosuke Sakuraia,
Koushi Haradaa,
Toshisaburo Nagaia,
William B. Rizzoa and
Shintaro Okadaa
a From the Department of Pediatrics (T.M., J.O., K.I., S.O.), Osaka University Medical School, the Department of Radiology (T.K.), Teikyo University medical School, the Department of Radiology (K.S.), Osaka Teisin Hospital, the Division of Radiology (K.H.), Kaizuka Municipal Hospital, the Department of Pediatrics (T.N.), Toyonaka Municipal Hospital, and the Departments of Pediatrics and Human Genetics (W.B.R.), Medical College of Virginia.

View larger version (44K):
[in a new window]
|
FIG 1. T2-weighted MR imaging (A) (4000/90 [TR/TE]) and 1H-MRS (B) in the deep white matter of the frontal lobe in Patient 1. The volumes of interest are indicated by square boxes. The spectra using longer echo times (140 and 270 ms) also showed the extra peaks at 1.3 ppm (black arrow) and at 0.9 ppm (white arrow). Note.Abbreviations: NAA, N-acetyl aspartate; PC, phosphocreatine; Cr, creatine; Cho, choline
| |

View larger version (50K):
[in a new window]
|
FIG 2. T2-weighted MR imaging (A) (4000/90) and 1H-MRS (B) in the deep white matter of the frontal lobe in Patient 2. 1H-MR spectra were similar to those shown in figure 1B
| |